Stephen Weiss, Founder, Short Hills Capital Partners

Headlines will have a minimal impact, because it takes YEARS to negotiate a trade deal. Trump will reduce tariffs on China to 80%--still high. And America dealing with 10% tariffs: that's still a big deal because our economy was still slowing. Don't buy false comfort ahead of the trade talks. Near term, we're okay, but he expects a recession ahead.

Loves it. Cutting edge and a leader in the defence space. But the valuation is too high (192x forward PE). He's been watching it a long time. He missed this completely.

He sold part of this. In Q1, the FDA approved a record low number of drugs, and Vertex has some important trials. Was nervous in a macro standpoint, but company fundamentals and valuation were reasonable. He hopes for a bounce.

Has been a problem child for a while and not worth the headache; there are better retailers. TGT faces a weaker consumer.

It's a trade. He bought Bitcoin below $90,000. Trump has strongly supported cryptos, so this still has momentum. It could return to $80K, but position this as a speculative asset in your portfolio. Others see value in it that he does not. The current move can continue to new highs.

What we heard from CEO Jensen Huang at the current tech conference is what we've heard in the several past quarters: there's insatiable demand for AI, and NVDA is the middle of this and it's good for the company. We heard nothing new. He's surprised shares are not even higher today (they are bouncing). The modest share increase isn't tied to NVDA, but tied to the fact that the market has been oversold. That said, will this bounce continued into the close and beyond? The market is in no man's land.

He likes Meta here, is fairly priced, despite the overall selling in tech in recent weeks. 

The analyst who downgraded GS is saying nothing new, including a delay in the M&A cycle. The IPO market will likely emerge in second-half 2025. Also consider is defaults will rise? Lending growth slow or reverse? The overall economy slow down?

MSFT is phasing out Windows 10 and pushing the 11 upgrade.

Shares are washed out from this correction.

Near term, this can't trade at prior multiples given volatility. Anything healthcare is uncertain. He still believes in the $600 price target. Great management. They have growth.